Imbruvica 57962-0007-12
Generic: Ibrutinib
- Manufacturer
- Pharmacyclics Llc
- Dosage Form
- Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 24, 2022
- Listing Expires
- December 31, 2027
- Application
- NDA217003
Need to source Imbruvica? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ibrutinib | 70 mg/mL |
Drug Class
Kinase Inhibitor [EPC]Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Selected Package
57962-0007-12Selected1 BOTTLE, GLASS in 1 CARTON (57962-007-12) / 108 mL in 1 BOTTLE, GLASS